Cite
HARVARD Citation
Zeuzem, S. et al. (2015). Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Alimentary pharmacology & therapeutics. 42 (7), pp. 829-844. [Online].